[HTML][HTML] Understanding Proton Magnetic Resonance Spectroscopy Neurochemical Changes Using Alzheimer's Disease Biofluid, PET, Postmortem Pathology …

F Kara, K Kantarci - International journal of molecular sciences, 2024 - mdpi.com
In vivo proton (1H) magnetic resonance spectroscopy (MRS) is a powerful non-invasive
method that can measure Alzheimer's disease (AD)-related neuropathological alterations at …

Multimodal investigation of neuropathology and neurometabolites in mild cognitive impairment and late-life depression with 11C-PiB beta-amyloid PET and 7T …

CW Davies-Jenkins, CI Workman, KE Hupfeld… - Neurobiology of …, 2024 - Elsevier
Positron emission tomography (PET) and magnetic resonance spectroscopy (1 H-MRS) are
complementary techniques that can be applied to study how proteinopathy and …

[HTML][HTML] Functional network centrality indicates interactions between APOE4 and age across the clinical spectrum of Alzheimer's Disease

AB Fall, MG Preti, M Eshmawey, SM Kagerer… - NeuroImage: Clinical, 2024 - Elsevier
Advanced age is the most important risk factor for Alzheimer's disease (AD), and carrier-
status of the Apolipoprotein E4 (APOE4) allele is the strongest known genetic risk factor …

[PDF][PDF] Review Not peer-reviewed version

F KARA, K Kantarci - 2024 - preprints.org
In vivo proton (1H) magnetic resonance spectroscopy (MRS) is a powerful noninvasive
method which can measure Alzheimer's disease (AD) related neuropathological alterations …